| The pivotal role of NF-kB in the pathogenesis and therapeutics of Alzheimer’s disease E Sun, A Motolani, L Campos, T Lu International journal of molecular sciences 23 (16), 8972, 2022 | 94 | 2022 |
| The structure and functions of PRMT5 in human diseases A Motolani, M Martin, M Sun, T Lu Life 11 (10), 1074, 2021 | 40 | 2021 |
| Phosphorylation of the regulators, a complex facet of NF-κB signaling in cancer A Motolani, M Martin, M Sun, T Lu Biomolecules 11 (1), 15, 2020 | 25 | 2020 |
| The pivotal player: components of NF-κB pathway as promising biomarkers in colorectal cancer M Martin, M Sun, A Motolani, T Lu International Journal of Molecular Sciences 22 (14), 7429, 2021 | 19 | 2021 |
| NF-κB and cancer therapy drugs A Motolani, M Martin, M Sun, T Lu Elsevier, 2022 | 6 | 2022 |
| Discovery of small molecule inhibitors for histone methyltransferases in cancer AA Motolani, M Sun, M Martin, S Sun, T Lu Translational research in cancer, 1, 2021 | 5 | 2021 |
| Inhibition of PRMT5 by market drugs as a novel cancer therapeutic avenue L Prabhu, M Martin, L Chen, Ö Demir, J Jin, X Huang, A Motolani, M Sun, ... Genes & Diseases 10 (1), 267-283, 2023 | 4 | 2023 |
| PRMT5 is a therapeutic target in choroidal neovascularization A Muniyandi, M Martin, K Sishtla, A Motolani, M Sun, NR Jensen, X Qi, ... Scientific Reports 13 (1), 1747, 2023 | 3 | 2023 |
| Genetic Alterations of NF-κB and Its Regulators: A Rich Platform to Advance Colorectal Cancer Diagnosis and Treatment F Alipourgivi, A Motolani, AY Qiu, W Qiang, GY Yang, S Chen, T Lu International Journal of Molecular Sciences 25 (1), 154, 2023 | 1 | 2023 |
| PRMT5 inhibitors for ocular therapy T Lu, TW Corson, M Martin, A Muniyandi, M Sun, K Sishtla, AA Motolani US Patent App. 18/061,219, 2023 | 1 | 2023 |
| A complex signature network that controls the upregulation of PRMT5 in colorectal cancer H Wei, AV Hartley, A Motolani, G Jiang, A Safa, L Prabhu, Y Liu, T Lu Genes & Diseases 9 (2), 285, 2022 | 1 | 2022 |
| KDM2A Deficiency in the Liver Promotes Abnormal Liver Function and Potential Liver Damage M Martin, A Motolani, HG Kim, AM Collins, F Alipourgivi, J Jin, H Wei, ... Biomolecules 13 (10), 1457, 2023 | | 2023 |
| Critical Role of Novel O-GlcNAcylation of S550 and S551 on the p65 Subunit of NF-κB in Pancreatic Cancer A Motolani, M Martin, B Wang, G Jiang, F Alipourgivi, X Huang, A Safa, ... Cancers 15 (19), 4742, 2023 | | 2023 |
| Critical role of OGT-mediated novel NF-κB o-glcNAcylation in pancreatic cancer A Motolani, M Martin, B Wang, G Jiang, Y Liu, T Lu Journal of Pharmacology and Experimental Therapeutics 385 (S3), 2023 | | 2023 |
| Repurposing Market Drugs to Target Epigenetic Enzymes in Human Diseases A Motolani, M Martin, S Sun, T Lu Drug Repurposing-Molecular Aspects and Therapeutic Applications, 2021 | | 2021 |
